nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C19—Memantine—Alzheimer's disease	0.246	0.51	CbGbCtD
Nilutamide—CYP2C9—Donepezil—Alzheimer's disease	0.236	0.489	CbGbCtD
Nilutamide—Melaena—Memantine—Alzheimer's disease	0.00286	0.00645	CcSEcCtD
Nilutamide—Abnormal vision—Donepezil—Alzheimer's disease	0.00281	0.00635	CcSEcCtD
Nilutamide—Melaena—Rivastigmine—Alzheimer's disease	0.0028	0.00631	CcSEcCtD
Nilutamide—Blood urea increased—Memantine—Alzheimer's disease	0.00276	0.00624	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Donepezil—Alzheimer's disease	0.00269	0.00607	CcSEcCtD
Nilutamide—Abnormal vision—Memantine—Alzheimer's disease	0.00255	0.00576	CcSEcCtD
Nilutamide—Libido decreased—Donepezil—Alzheimer's disease	0.00252	0.0057	CcSEcCtD
Nilutamide—Hot flush—Donepezil—Alzheimer's disease	0.0025	0.00565	CcSEcCtD
Nilutamide—Abnormal vision—Rivastigmine—Alzheimer's disease	0.0025	0.00564	CcSEcCtD
Nilutamide—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00248	0.0056	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.00244	0.00551	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00243	0.00547	CcSEcCtD
Nilutamide—Arthritis—Donepezil—Alzheimer's disease	0.00241	0.00543	CcSEcCtD
Nilutamide—Cardiac failure—Donepezil—Alzheimer's disease	0.0024	0.00541	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.00239	0.00539	CcSEcCtD
Nilutamide—Weight decreased—Galantamine—Alzheimer's disease	0.00236	0.00533	CcSEcCtD
Nilutamide—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00235	0.00531	CcSEcCtD
Nilutamide—Pneumonia—Galantamine—Alzheimer's disease	0.00234	0.00528	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00234	0.00528	CcSEcCtD
Nilutamide—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00232	0.00524	CcSEcCtD
Nilutamide—Depression—Galantamine—Alzheimer's disease	0.00232	0.00524	CcSEcCtD
Nilutamide—Libido decreased—Memantine—Alzheimer's disease	0.00229	0.00517	CcSEcCtD
Nilutamide—Hot flush—Memantine—Alzheimer's disease	0.00227	0.00513	CcSEcCtD
Nilutamide—Urinary tract infection—Galantamine—Alzheimer's disease	0.00226	0.00511	CcSEcCtD
Nilutamide—Menopausal symptoms—Memantine—Alzheimer's disease	0.00225	0.00508	CcSEcCtD
Nilutamide—Libido decreased—Rivastigmine—Alzheimer's disease	0.00224	0.00506	CcSEcCtD
Nilutamide—Hot flush—Rivastigmine—Alzheimer's disease	0.00222	0.00502	CcSEcCtD
Nilutamide—Haematuria—Galantamine—Alzheimer's disease	0.00222	0.00501	CcSEcCtD
Nilutamide—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.0022	0.00497	CcSEcCtD
Nilutamide—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00219	0.00495	CcSEcCtD
Nilutamide—Arthritis—Memantine—Alzheimer's disease	0.00219	0.00493	CcSEcCtD
Nilutamide—Cardiac failure—Memantine—Alzheimer's disease	0.00218	0.00491	CcSEcCtD
Nilutamide—Dry skin—Donepezil—Alzheimer's disease	0.00214	0.00484	CcSEcCtD
Nilutamide—Arthritis—Rivastigmine—Alzheimer's disease	0.00214	0.00483	CcSEcCtD
Nilutamide—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00213	0.00481	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00212	0.0048	CcSEcCtD
Nilutamide—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00211	0.00476	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00211	0.00476	CcSEcCtD
Nilutamide—Rhinitis—Galantamine—Alzheimer's disease	0.00209	0.00473	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00208	0.00469	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00206	0.00466	CcSEcCtD
Nilutamide—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00206	0.00466	CcSEcCtD
Nilutamide—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00206	0.00465	CcSEcCtD
Nilutamide—Oedema peripheral—Galantamine—Alzheimer's disease	0.00206	0.00464	CcSEcCtD
Nilutamide—Urethral disorder—Galantamine—Alzheimer's disease	0.00205	0.00462	CcSEcCtD
Nilutamide—Influenza—Donepezil—Alzheimer's disease	0.00202	0.00457	CcSEcCtD
Nilutamide—Visual impairment—Galantamine—Alzheimer's disease	0.00201	0.00454	CcSEcCtD
Nilutamide—Blood creatinine increased—Memantine—Alzheimer's disease	0.00199	0.00449	CcSEcCtD
Nilutamide—Angina pectoris—Donepezil—Alzheimer's disease	0.00197	0.00445	CcSEcCtD
Nilutamide—Dry skin—Memantine—Alzheimer's disease	0.00195	0.0044	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00191	0.00432	CcSEcCtD
Nilutamide—Dry skin—Rivastigmine—Alzheimer's disease	0.0019	0.0043	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00187	0.00423	CcSEcCtD
Nilutamide—Influenza—Memantine—Alzheimer's disease	0.00184	0.00415	CcSEcCtD
Nilutamide—Weight decreased—Donepezil—Alzheimer's disease	0.00183	0.00413	CcSEcCtD
Nilutamide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00182	0.00412	CcSEcCtD
Nilutamide—Pneumonia—Donepezil—Alzheimer's disease	0.00181	0.00409	CcSEcCtD
Nilutamide—Depression—Donepezil—Alzheimer's disease	0.0018	0.00406	CcSEcCtD
Nilutamide—Angina pectoris—Memantine—Alzheimer's disease	0.00179	0.00404	CcSEcCtD
Nilutamide—Tension—Galantamine—Alzheimer's disease	0.00178	0.00403	CcSEcCtD
Nilutamide—Nervousness—Galantamine—Alzheimer's disease	0.00177	0.00399	CcSEcCtD
Nilutamide—Back pain—Galantamine—Alzheimer's disease	0.00176	0.00397	CcSEcCtD
Nilutamide—Urinary tract infection—Donepezil—Alzheimer's disease	0.00175	0.00396	CcSEcCtD
Nilutamide—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00175	0.00395	CcSEcCtD
Nilutamide—Sweating—Donepezil—Alzheimer's disease	0.00173	0.0039	CcSEcCtD
Nilutamide—Haematuria—Donepezil—Alzheimer's disease	0.00172	0.00388	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00171	0.00385	CcSEcCtD
Nilutamide—Erectile dysfunction—Memantine—Alzheimer's disease	0.00169	0.00382	CcSEcCtD
Nilutamide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00169	0.00381	CcSEcCtD
Nilutamide—Anaemia—Galantamine—Alzheimer's disease	0.00168	0.00379	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00167	0.00377	CcSEcCtD
Nilutamide—Weight decreased—Memantine—Alzheimer's disease	0.00166	0.00375	CcSEcCtD
Nilutamide—Hyperglycaemia—Memantine—Alzheimer's disease	0.00166	0.00374	CcSEcCtD
Nilutamide—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00165	0.00373	CcSEcCtD
Nilutamide—Pneumonia—Memantine—Alzheimer's disease	0.00165	0.00372	CcSEcCtD
Nilutamide—Malaise—Galantamine—Alzheimer's disease	0.00164	0.0037	CcSEcCtD
Nilutamide—Depression—Memantine—Alzheimer's disease	0.00163	0.00369	CcSEcCtD
Nilutamide—Syncope—Galantamine—Alzheimer's disease	0.00163	0.00368	CcSEcCtD
Nilutamide—Weight decreased—Rivastigmine—Alzheimer's disease	0.00163	0.00367	CcSEcCtD
Nilutamide—Rhinitis—Donepezil—Alzheimer's disease	0.00162	0.00366	CcSEcCtD
Nilutamide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00162	0.00366	CcSEcCtD
Nilutamide—Pneumonia—Rivastigmine—Alzheimer's disease	0.00161	0.00364	CcSEcCtD
Nilutamide—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00161	0.00364	CcSEcCtD
Nilutamide—Urinary tract disorder—Donepezil—Alzheimer's disease	0.0016	0.00361	CcSEcCtD
Nilutamide—Loss of consciousness—Galantamine—Alzheimer's disease	0.0016	0.00361	CcSEcCtD
Nilutamide—Depression—Rivastigmine—Alzheimer's disease	0.0016	0.00361	CcSEcCtD
Nilutamide—Oedema peripheral—Donepezil—Alzheimer's disease	0.00159	0.0036	CcSEcCtD
Nilutamide—Urinary tract infection—Memantine—Alzheimer's disease	0.00159	0.00359	CcSEcCtD
Nilutamide—Urethral disorder—Donepezil—Alzheimer's disease	0.00159	0.00358	CcSEcCtD
Nilutamide—Cough—Galantamine—Alzheimer's disease	0.00159	0.00358	CcSEcCtD
Nilutamide—Hypertension—Galantamine—Alzheimer's disease	0.00157	0.00354	CcSEcCtD
Nilutamide—Haematuria—Memantine—Alzheimer's disease	0.00156	0.00352	CcSEcCtD
Nilutamide—Visual impairment—Donepezil—Alzheimer's disease	0.00156	0.00352	CcSEcCtD
Nilutamide—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00156	0.00351	CcSEcCtD
Nilutamide—Chest pain—Galantamine—Alzheimer's disease	0.00155	0.00349	CcSEcCtD
Nilutamide—Sweating—Rivastigmine—Alzheimer's disease	0.00154	0.00347	CcSEcCtD
Nilutamide—Discomfort—Galantamine—Alzheimer's disease	0.00153	0.00345	CcSEcCtD
Nilutamide—Haematuria—Rivastigmine—Alzheimer's disease	0.00153	0.00345	CcSEcCtD
Nilutamide—Dry mouth—Galantamine—Alzheimer's disease	0.00151	0.00342	CcSEcCtD
Nilutamide—Rhinitis—Memantine—Alzheimer's disease	0.00147	0.00333	CcSEcCtD
Nilutamide—Hypoaesthesia—Memantine—Alzheimer's disease	0.00146	0.0033	CcSEcCtD
Nilutamide—Shock—Galantamine—Alzheimer's disease	0.00146	0.0033	CcSEcCtD
Nilutamide—Urinary tract disorder—Memantine—Alzheimer's disease	0.00145	0.00328	CcSEcCtD
Nilutamide—Oedema peripheral—Memantine—Alzheimer's disease	0.00145	0.00327	CcSEcCtD
Nilutamide—Rhinitis—Rivastigmine—Alzheimer's disease	0.00144	0.00325	CcSEcCtD
Nilutamide—Urethral disorder—Memantine—Alzheimer's disease	0.00144	0.00325	CcSEcCtD
Nilutamide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00143	0.00324	CcSEcCtD
Nilutamide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00143	0.00323	CcSEcCtD
Nilutamide—Alopecia—Donepezil—Alzheimer's disease	0.00143	0.00323	CcSEcCtD
Nilutamide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00142	0.00321	CcSEcCtD
Nilutamide—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00142	0.0032	CcSEcCtD
Nilutamide—Visual impairment—Memantine—Alzheimer's disease	0.00142	0.0032	CcSEcCtD
Nilutamide—Anorexia—Galantamine—Alzheimer's disease	0.00141	0.00319	CcSEcCtD
Nilutamide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00141	0.00318	CcSEcCtD
Nilutamide—Visual impairment—Rivastigmine—Alzheimer's disease	0.00139	0.00313	CcSEcCtD
Nilutamide—Tension—Donepezil—Alzheimer's disease	0.00138	0.00312	CcSEcCtD
Nilutamide—Enzalutamide—CYP2D6—Alzheimer's disease	0.00138	1	CrCbGaD
Nilutamide—Nervousness—Donepezil—Alzheimer's disease	0.00137	0.00309	CcSEcCtD
Nilutamide—Back pain—Donepezil—Alzheimer's disease	0.00136	0.00308	CcSEcCtD
Nilutamide—Insomnia—Galantamine—Alzheimer's disease	0.00134	0.00303	CcSEcCtD
Nilutamide—Paraesthesia—Galantamine—Alzheimer's disease	0.00133	0.00301	CcSEcCtD
Nilutamide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00131	0.00295	CcSEcCtD
Nilutamide—Dyspepsia—Galantamine—Alzheimer's disease	0.00131	0.00295	CcSEcCtD
Nilutamide—Anaemia—Donepezil—Alzheimer's disease	0.0013	0.00294	CcSEcCtD
Nilutamide—Alopecia—Memantine—Alzheimer's disease	0.0013	0.00293	CcSEcCtD
Nilutamide—Decreased appetite—Galantamine—Alzheimer's disease	0.00129	0.00291	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00128	0.00289	CcSEcCtD
Nilutamide—Malaise—Donepezil—Alzheimer's disease	0.00127	0.00287	CcSEcCtD
Nilutamide—Alopecia—Rivastigmine—Alzheimer's disease	0.00127	0.00287	CcSEcCtD
Nilutamide—Constipation—Galantamine—Alzheimer's disease	0.00127	0.00286	CcSEcCtD
Nilutamide—Syncope—Donepezil—Alzheimer's disease	0.00126	0.00285	CcSEcCtD
Nilutamide—Tension—Memantine—Alzheimer's disease	0.00126	0.00283	CcSEcCtD
Nilutamide—Nervousness—Memantine—Alzheimer's disease	0.00124	0.00281	CcSEcCtD
Nilutamide—Loss of consciousness—Donepezil—Alzheimer's disease	0.00124	0.0028	CcSEcCtD
Nilutamide—Back pain—Memantine—Alzheimer's disease	0.00124	0.00279	CcSEcCtD
Nilutamide—Cough—Donepezil—Alzheimer's disease	0.00123	0.00278	CcSEcCtD
Nilutamide—Tension—Rivastigmine—Alzheimer's disease	0.00123	0.00277	CcSEcCtD
Nilutamide—Feeling abnormal—Galantamine—Alzheimer's disease	0.00122	0.00276	CcSEcCtD
Nilutamide—Hypertension—Donepezil—Alzheimer's disease	0.00122	0.00275	CcSEcCtD
Nilutamide—Nervousness—Rivastigmine—Alzheimer's disease	0.00122	0.00274	CcSEcCtD
Nilutamide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00121	0.00274	CcSEcCtD
Nilutamide—Back pain—Rivastigmine—Alzheimer's disease	0.00121	0.00273	CcSEcCtD
Nilutamide—Chest pain—Donepezil—Alzheimer's disease	0.0012	0.00271	CcSEcCtD
Nilutamide—Ill-defined disorder—Memantine—Alzheimer's disease	0.00119	0.00268	CcSEcCtD
Nilutamide—Discomfort—Donepezil—Alzheimer's disease	0.00119	0.00268	CcSEcCtD
Nilutamide—Anaemia—Memantine—Alzheimer's disease	0.00118	0.00267	CcSEcCtD
Nilutamide—Dry mouth—Donepezil—Alzheimer's disease	0.00117	0.00265	CcSEcCtD
Nilutamide—Body temperature increased—Galantamine—Alzheimer's disease	0.00117	0.00265	CcSEcCtD
Nilutamide—Abdominal pain—Galantamine—Alzheimer's disease	0.00117	0.00265	CcSEcCtD
Nilutamide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00262	CcSEcCtD
Nilutamide—Anaemia—Rivastigmine—Alzheimer's disease	0.00116	0.00261	CcSEcCtD
Nilutamide—Malaise—Memantine—Alzheimer's disease	0.00115	0.0026	CcSEcCtD
Nilutamide—Oedema—Donepezil—Alzheimer's disease	0.00115	0.0026	CcSEcCtD
Nilutamide—Syncope—Memantine—Alzheimer's disease	0.00115	0.00259	CcSEcCtD
Nilutamide—Leukopenia—Memantine—Alzheimer's disease	0.00115	0.00259	CcSEcCtD
Nilutamide—Shock—Donepezil—Alzheimer's disease	0.00113	0.00255	CcSEcCtD
Nilutamide—Malaise—Rivastigmine—Alzheimer's disease	0.00113	0.00255	CcSEcCtD
Nilutamide—Loss of consciousness—Memantine—Alzheimer's disease	0.00112	0.00254	CcSEcCtD
Nilutamide—Syncope—Rivastigmine—Alzheimer's disease	0.00112	0.00253	CcSEcCtD
Nilutamide—Cough—Memantine—Alzheimer's disease	0.00112	0.00252	CcSEcCtD
Nilutamide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00111	0.00251	CcSEcCtD
Nilutamide—Hypertension—Memantine—Alzheimer's disease	0.0011	0.00249	CcSEcCtD
Nilutamide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.0011	0.00248	CcSEcCtD
Nilutamide—Anorexia—Donepezil—Alzheimer's disease	0.0011	0.00247	CcSEcCtD
Nilutamide—Cough—Rivastigmine—Alzheimer's disease	0.00109	0.00247	CcSEcCtD
Nilutamide—Chest pain—Memantine—Alzheimer's disease	0.00109	0.00246	CcSEcCtD
Nilutamide—Hypertension—Rivastigmine—Alzheimer's disease	0.00108	0.00244	CcSEcCtD
Nilutamide—Discomfort—Memantine—Alzheimer's disease	0.00108	0.00243	CcSEcCtD
Nilutamide—Chest pain—Rivastigmine—Alzheimer's disease	0.00107	0.00241	CcSEcCtD
Nilutamide—Dry mouth—Memantine—Alzheimer's disease	0.00107	0.0024	CcSEcCtD
Nilutamide—Asthenia—Galantamine—Alzheimer's disease	0.00106	0.0024	CcSEcCtD
Nilutamide—Discomfort—Rivastigmine—Alzheimer's disease	0.00105	0.00238	CcSEcCtD
Nilutamide—Oedema—Memantine—Alzheimer's disease	0.00104	0.00236	CcSEcCtD
Nilutamide—Dry mouth—Rivastigmine—Alzheimer's disease	0.00104	0.00235	CcSEcCtD
Nilutamide—Insomnia—Donepezil—Alzheimer's disease	0.00104	0.00235	CcSEcCtD
Nilutamide—Paraesthesia—Donepezil—Alzheimer's disease	0.00103	0.00233	CcSEcCtD
Nilutamide—Shock—Memantine—Alzheimer's disease	0.00103	0.00232	CcSEcCtD
Nilutamide—Dyspnoea—Donepezil—Alzheimer's disease	0.00103	0.00231	CcSEcCtD
Nilutamide—Oedema—Rivastigmine—Alzheimer's disease	0.00102	0.00231	CcSEcCtD
Nilutamide—Diarrhoea—Galantamine—Alzheimer's disease	0.00102	0.00229	CcSEcCtD
Nilutamide—Dyspepsia—Donepezil—Alzheimer's disease	0.00101	0.00229	CcSEcCtD
Nilutamide—Hyperhidrosis—Memantine—Alzheimer's disease	0.00101	0.00228	CcSEcCtD
Nilutamide—Shock—Rivastigmine—Alzheimer's disease	0.001	0.00227	CcSEcCtD
Nilutamide—Decreased appetite—Donepezil—Alzheimer's disease	0.001	0.00226	CcSEcCtD
Nilutamide—Anorexia—Memantine—Alzheimer's disease	0.000995	0.00225	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000993	0.00224	CcSEcCtD
Nilutamide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000987	0.00223	CcSEcCtD
Nilutamide—Constipation—Donepezil—Alzheimer's disease	0.000983	0.00222	CcSEcCtD
Nilutamide—Pain—Donepezil—Alzheimer's disease	0.000983	0.00222	CcSEcCtD
Nilutamide—Dizziness—Galantamine—Alzheimer's disease	0.000981	0.00222	CcSEcCtD
Nilutamide—Anorexia—Rivastigmine—Alzheimer's disease	0.000974	0.0022	CcSEcCtD
Nilutamide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000948	0.00214	CcSEcCtD
Nilutamide—Insomnia—Memantine—Alzheimer's disease	0.000944	0.00213	CcSEcCtD
Nilutamide—Vomiting—Galantamine—Alzheimer's disease	0.000943	0.00213	CcSEcCtD
Nilutamide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00094	0.00212	CcSEcCtD
Nilutamide—Paraesthesia—Memantine—Alzheimer's disease	0.000938	0.00212	CcSEcCtD
Nilutamide—Rash—Galantamine—Alzheimer's disease	0.000936	0.00211	CcSEcCtD
Nilutamide—Dermatitis—Galantamine—Alzheimer's disease	0.000935	0.00211	CcSEcCtD
Nilutamide—Dyspnoea—Memantine—Alzheimer's disease	0.000931	0.0021	CcSEcCtD
Nilutamide—Headache—Galantamine—Alzheimer's disease	0.00093	0.0021	CcSEcCtD
Nilutamide—Insomnia—Rivastigmine—Alzheimer's disease	0.000924	0.00209	CcSEcCtD
Nilutamide—Dyspepsia—Memantine—Alzheimer's disease	0.000919	0.00207	CcSEcCtD
Nilutamide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000917	0.00207	CcSEcCtD
Nilutamide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000911	0.00206	CcSEcCtD
Nilutamide—Body temperature increased—Donepezil—Alzheimer's disease	0.000909	0.00205	CcSEcCtD
Nilutamide—Abdominal pain—Donepezil—Alzheimer's disease	0.000909	0.00205	CcSEcCtD
Nilutamide—Decreased appetite—Memantine—Alzheimer's disease	0.000908	0.00205	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000901	0.00204	CcSEcCtD
Nilutamide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000899	0.00203	CcSEcCtD
Nilutamide—Constipation—Memantine—Alzheimer's disease	0.000893	0.00202	CcSEcCtD
Nilutamide—Pain—Memantine—Alzheimer's disease	0.000893	0.00202	CcSEcCtD
Nilutamide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000888	0.002	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000882	0.00199	CcSEcCtD
Nilutamide—Nausea—Galantamine—Alzheimer's disease	0.000881	0.00199	CcSEcCtD
Nilutamide—Pain—Rivastigmine—Alzheimer's disease	0.000873	0.00197	CcSEcCtD
Nilutamide—Constipation—Rivastigmine—Alzheimer's disease	0.000873	0.00197	CcSEcCtD
Nilutamide—Feeling abnormal—Memantine—Alzheimer's disease	0.00086	0.00194	CcSEcCtD
Nilutamide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000854	0.00193	CcSEcCtD
Nilutamide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000842	0.0019	CcSEcCtD
Nilutamide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000835	0.00189	CcSEcCtD
Nilutamide—Abdominal pain—Memantine—Alzheimer's disease	0.000825	0.00186	CcSEcCtD
Nilutamide—Body temperature increased—Memantine—Alzheimer's disease	0.000825	0.00186	CcSEcCtD
Nilutamide—Asthenia—Donepezil—Alzheimer's disease	0.000825	0.00186	CcSEcCtD
Nilutamide—Pruritus—Donepezil—Alzheimer's disease	0.000814	0.00184	CcSEcCtD
Nilutamide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000807	0.00182	CcSEcCtD
Nilutamide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000807	0.00182	CcSEcCtD
Nilutamide—Diarrhoea—Donepezil—Alzheimer's disease	0.000787	0.00178	CcSEcCtD
Nilutamide—Dizziness—Donepezil—Alzheimer's disease	0.00076	0.00172	CcSEcCtD
Nilutamide—Asthenia—Memantine—Alzheimer's disease	0.000749	0.00169	CcSEcCtD
Nilutamide—Pruritus—Memantine—Alzheimer's disease	0.000739	0.00167	CcSEcCtD
Nilutamide—Asthenia—Rivastigmine—Alzheimer's disease	0.000733	0.00165	CcSEcCtD
Nilutamide—Vomiting—Donepezil—Alzheimer's disease	0.000731	0.00165	CcSEcCtD
Nilutamide—Rash—Donepezil—Alzheimer's disease	0.000725	0.00164	CcSEcCtD
Nilutamide—Dermatitis—Donepezil—Alzheimer's disease	0.000724	0.00164	CcSEcCtD
Nilutamide—Pruritus—Rivastigmine—Alzheimer's disease	0.000723	0.00163	CcSEcCtD
Nilutamide—Headache—Donepezil—Alzheimer's disease	0.00072	0.00163	CcSEcCtD
Nilutamide—Diarrhoea—Memantine—Alzheimer's disease	0.000714	0.00161	CcSEcCtD
Nilutamide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000699	0.00158	CcSEcCtD
Nilutamide—Dizziness—Memantine—Alzheimer's disease	0.00069	0.00156	CcSEcCtD
Nilutamide—Nausea—Donepezil—Alzheimer's disease	0.000683	0.00154	CcSEcCtD
Nilutamide—Dizziness—Rivastigmine—Alzheimer's disease	0.000675	0.00152	CcSEcCtD
Nilutamide—Vomiting—Memantine—Alzheimer's disease	0.000664	0.0015	CcSEcCtD
Nilutamide—Rash—Memantine—Alzheimer's disease	0.000658	0.00149	CcSEcCtD
Nilutamide—Dermatitis—Memantine—Alzheimer's disease	0.000658	0.00148	CcSEcCtD
Nilutamide—Headache—Memantine—Alzheimer's disease	0.000654	0.00148	CcSEcCtD
Nilutamide—Vomiting—Rivastigmine—Alzheimer's disease	0.000649	0.00147	CcSEcCtD
Nilutamide—Rash—Rivastigmine—Alzheimer's disease	0.000644	0.00145	CcSEcCtD
Nilutamide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000643	0.00145	CcSEcCtD
Nilutamide—Headache—Rivastigmine—Alzheimer's disease	0.00064	0.00144	CcSEcCtD
Nilutamide—Nausea—Memantine—Alzheimer's disease	0.00062	0.0014	CcSEcCtD
Nilutamide—Nausea—Rivastigmine—Alzheimer's disease	0.000607	0.00137	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.00034	0.00461	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000339	0.0046	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000337	0.00458	CbGpPWpGaD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000334	0.00454	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000334	0.00453	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00033	0.00448	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP46A1—Alzheimer's disease	0.000329	0.00447	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000328	0.00445	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000328	0.00445	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000325	0.00442	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000324	0.0044	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000318	0.00431	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000312	0.00424	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.00031	0.00421	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000309	0.0042	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000308	0.00419	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000302	0.0041	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000301	0.00408	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CAV1—Alzheimer's disease	0.000298	0.00405	CbGpPWpGaD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000298	0.00405	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP46A1—Alzheimer's disease	0.000294	0.00399	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000289	0.00393	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00028	0.0038	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000279	0.00379	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000276	0.00375	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000276	0.00374	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000275	0.00373	CbGpPWpGaD
Nilutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000272	0.00369	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000272	0.00369	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000268	0.00363	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000267	0.00363	CbGpPWpGaD
Nilutamide—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000266	0.00362	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000264	0.00358	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	0.000261	0.00354	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	0.000259	0.00351	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000252	0.00342	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00025	0.00339	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000245	0.00333	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000245	0.00332	CbGpPWpGaD
Nilutamide—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.000241	0.00327	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000235	0.00319	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000234	0.00317	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000228	0.00309	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000227	0.00309	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000223	0.00303	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000217	0.00295	CbGpPWpGaD
Nilutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000216	0.00293	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000208	0.00283	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000207	0.00281	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PHF1—Alzheimer's disease	0.000197	0.00268	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—MAOB—Alzheimer's disease	0.000196	0.00266	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000194	0.00263	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000189	0.00257	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.000188	0.00256	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—MAOB—Alzheimer's disease	0.000175	0.00238	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.000169	0.0023	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000169	0.00229	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000165	0.00224	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.00016	0.00217	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000156	0.00212	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000154	0.00209	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000153	0.00208	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—PTGS1—Alzheimer's disease	0.000149	0.00202	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP2D6—Alzheimer's disease	0.000146	0.00198	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000144	0.00195	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.000142	0.00193	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.00014	0.00191	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	0.00014	0.0019	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000137	0.00186	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000137	0.00186	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000135	0.00183	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	0.000133	0.0018	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	0.00013	0.00177	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000128	0.00174	CbGpPWpGaD
Nilutamide—AR—Gene Expression—TFAM—Alzheimer's disease	0.000127	0.00172	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000126	0.00171	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.000125	0.0017	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000125	0.00169	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000123	0.00166	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000122	0.00166	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000122	0.00166	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	0.000121	0.00164	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	0.000119	0.00161	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000118	0.0016	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000117	0.00159	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000113	0.00153	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.000112	0.00152	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.000112	0.00152	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000111	0.00151	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.000106	0.00145	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.000104	0.00141	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000104	0.00141	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	0.000104	0.00141	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000103	0.0014	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	9.56e-05	0.0013	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	8.89e-05	0.00121	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	8.82e-05	0.0012	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	8.43e-05	0.00114	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	8.1e-05	0.0011	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	8.05e-05	0.00109	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	7.86e-05	0.00107	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	7.75e-05	0.00105	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EIF2S1—Alzheimer's disease	7.64e-05	0.00104	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	7.56e-05	0.00103	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	7.52e-05	0.00102	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	7.49e-05	0.00102	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	7.17e-05	0.000974	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA4—Alzheimer's disease	7.17e-05	0.000973	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	7.07e-05	0.00096	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	7.01e-05	0.000952	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7e-05	0.000951	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	6.86e-05	0.000931	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	6.79e-05	0.000923	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	6.74e-05	0.000915	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	6.67e-05	0.000905	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA4—Alzheimer's disease	6.4e-05	0.000869	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	6.4e-05	0.000868	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	6.39e-05	0.000867	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	6.25e-05	0.000849	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLD3—Alzheimer's disease	6.09e-05	0.000827	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.09e-05	0.000827	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.02e-05	0.000818	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	6.01e-05	0.000817	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	5.84e-05	0.000793	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA4—Alzheimer's disease	5.83e-05	0.000792	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.71e-05	0.000775	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	5.7e-05	0.000774	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.7e-05	0.000774	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	5.63e-05	0.000764	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	5.62e-05	0.000764	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	5.48e-05	0.000745	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLD3—Alzheimer's disease	5.44e-05	0.000739	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.44e-05	0.000739	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ND1—Alzheimer's disease	5.43e-05	0.000737	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.38e-05	0.00073	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.31e-05	0.000721	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	5.21e-05	0.000708	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	5.2e-05	0.000706	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.1e-05	0.000692	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	5.02e-05	0.000682	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	4.96e-05	0.000673	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.96e-05	0.000673	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.9e-05	0.000666	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.85e-05	0.000659	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ND1—Alzheimer's disease	4.85e-05	0.000658	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	4.75e-05	0.000646	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.74e-05	0.000643	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.65e-05	0.000631	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	4.58e-05	0.000621	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ND1—Alzheimer's disease	4.42e-05	0.0006	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.33e-05	0.000588	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.32e-05	0.000587	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.18e-05	0.000568	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.95e-05	0.000537	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.81e-05	0.000517	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.73e-05	0.000507	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ESR1—Alzheimer's disease	3.73e-05	0.000507	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH1—Alzheimer's disease	3.61e-05	0.00049	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TPI1—Alzheimer's disease	3.5e-05	0.000475	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CHAT—Alzheimer's disease	3.5e-05	0.000475	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.41e-05	0.000462	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—Alzheimer's disease	3.41e-05	0.000462	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.4e-05	0.000462	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MAOB—Alzheimer's disease	3.36e-05	0.000456	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	3.23e-05	0.000439	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.19e-05	0.000434	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.16e-05	0.00043	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CHAT—Alzheimer's disease	3.12e-05	0.000424	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TPI1—Alzheimer's disease	3.12e-05	0.000424	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—A2M—Alzheimer's disease	3.12e-05	0.000424	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.1e-05	0.000421	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MAOB—Alzheimer's disease	2.99e-05	0.000407	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	2.88e-05	0.000391	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.85e-05	0.000387	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	2.85e-05	0.000387	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	2.85e-05	0.000387	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.82e-05	0.000383	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—A2M—Alzheimer's disease	2.78e-05	0.000378	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.78e-05	0.000378	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	2.73e-05	0.000371	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ACHE—Alzheimer's disease	2.71e-05	0.000368	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	2.68e-05	0.000364	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	2.63e-05	0.000357	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.6e-05	0.000353	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.58e-05	0.00035	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ENO1—Alzheimer's disease	2.54e-05	0.000345	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	2.54e-05	0.000345	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—A2M—Alzheimer's disease	2.54e-05	0.000345	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	2.49e-05	0.000339	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.48e-05	0.000337	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ACHE—Alzheimer's disease	2.42e-05	0.000329	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	2.39e-05	0.000325	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—BCHE—Alzheimer's disease	2.36e-05	0.000321	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	2.27e-05	0.000308	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ENO1—Alzheimer's disease	2.27e-05	0.000308	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.26e-05	0.000307	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	2.23e-05	0.000303	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	2.23e-05	0.000302	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	2.21e-05	0.0003	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.19e-05	0.000297	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	2.18e-05	0.000296	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	2.16e-05	0.000294	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—BCHE—Alzheimer's disease	2.11e-05	0.000287	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	2.07e-05	0.000281	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	2.07e-05	0.000281	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	2.03e-05	0.000276	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.99e-05	0.00027	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.95e-05	0.000265	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.93e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.92e-05	0.000261	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.86e-05	0.000253	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1.86e-05	0.000252	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.82e-05	0.000247	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.78e-05	0.000242	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.76e-05	0.000239	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LPL—Alzheimer's disease	1.7e-05	0.00023	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.66e-05	0.000226	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.66e-05	0.000225	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	1.53e-05	0.000207	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.52e-05	0.000206	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.51e-05	0.000206	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.51e-05	0.000205	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CALM1—Alzheimer's disease	1.43e-05	0.000194	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOE—Alzheimer's disease	1.42e-05	0.000193	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAV1—Alzheimer's disease	1.41e-05	0.000191	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.38e-05	0.000188	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.36e-05	0.000185	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—Alzheimer's disease	1.35e-05	0.000183	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.27e-05	0.000173	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.27e-05	0.000172	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.26e-05	0.000171	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.24e-05	0.000169	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—Alzheimer's disease	1.24e-05	0.000168	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—INS—Alzheimer's disease	1.21e-05	0.000165	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.16e-05	0.000158	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.16e-05	0.000157	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.15e-05	0.000156	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.11e-05	0.00015	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—INS—Alzheimer's disease	1.08e-05	0.000147	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.07e-05	0.000145	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.01e-05	0.000137	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—INS—Alzheimer's disease	9.89e-06	0.000134	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	9.74e-06	0.000132	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—Alzheimer's disease	9.51e-06	0.000129	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	8.7e-06	0.000118	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	8.67e-06	0.000118	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	7.93e-06	0.000108	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—Alzheimer's disease	4.9e-06	6.65e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—Alzheimer's disease	4.37e-06	5.94e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	3.99e-06	5.41e-05	CbGpPWpGaD
